🇺🇸 FDA
Pipeline program

Pegasys 180 micrograms solution for injection in pre-filled syringe, VIR-3434, Viread 245 mg film-coated tablets, VIR-2218

VIR-MHB1-V200

Phase 2 small_molecule active

Quick answer

Pegasys 180 micrograms solution for injection in pre-filled syringe, VIR-3434, Viread 245 mg film-coated tablets, VIR-2218 for Chronic Hepatitis B Virus (HBV) Infection is a Phase 2 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Vir Biotechnology
Indication
Chronic Hepatitis B Virus (HBV) Infection
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials